[8-K] DIH Holdings US, Inc. Reports Material Event

Rhea-AI Filing Summary

DIH Holding US, Inc. (Nasdaq: DHAI) filed a Form 8-K reporting the 4 Aug 2025 appointment of Scott R. Burell to its Board of Directors. Burell, an experienced healthcare CFO now serving at AIVITA Biomedical and formerly at CombiMatrix during its sale to Invitae, joins as a Class III director with a term expiring at the 2026 annual meeting. He will also sit on the Audit, Compensation, and Nominating & Corporate Governance Committees, adding finance and transaction expertise to these key oversight bodies. The company noted no related-party transactions under Item 404 and did not disclose new compensatory arrangements. An accompanying press release (Ex. 99.1) dated 7 Aug 2025 announces the move. No other operational or financial updates were included.

Positive

• Board strengthened by adding veteran CFO Scott R. Burell to Audit, Compensation and Nominating committees

Negative

• No financial or strategic guidance accompanying the director appointment, limiting immediate investor impact

Insights

Corporate Governance Analyst

TL;DR: Board gains proven CFO; governance strengthened, but limited immediate financial impact—overall neutral.

The appointment of Scott R. Burell adds deep capital-markets and M&A experience to three critical committees, which should enhance board oversight and strategic optionality. His background steering CombiMatrix through a successful sale suggests familiarity with corporate transactions that could benefit DHAI’s growth plans. However, the filing lacks details on new strategy, compensation, or financial performance, so the event is unlikely to move valuation in the short term.

Portfolio Manager

TL;DR: Talent upgrade is incrementally positive but not thesis-changing; maintain watch.

Burell’s track record in fundraising and exits is a modest positive signal for future capital allocation. Yet without guidance revisions or transaction announcements, risk-reward for DHAI remains governed by core operations. I view the disclosure as good housekeeping rather than a catalyst.

false 0001883788 0001883788 2025-08-04 2025-08-04 0001883788 DHAI:ClassCommonStockMember 2025-08-04 2025-08-04 0001883788 DHAI:WarrantsMember 2025-08-04 2025-08-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 4, 2025

DIH HOLDING US, INC.

(Exact name of Registrant as Specified in Its Charter)

Delaware		001-41250		98-1624542
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

77 Accord Park Drive; Suite D-1 Norwell, Massachusetts		02061
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: 877 944-2200

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A Common Stock		DHAI		The Nasdaq Stock Market LLC
Warrants		DHAIW		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

(d) On August 4, 2025, the Board of Directors of DIH Holding US, Inc. (the “Registrant”), upon recommendation of the Nominating Committee of the Board, appointed Scott R. Burell to the Board of Directors. He has been appointed to Class III with a term to expire at the 2026 Annual Meeting of Stockholders. He has also been appointed to serve on the Audit, Compensation and Nominating and Corporate Governance Committees. There are no items required to be disclosed by Item 404 of Regulation S-K.

Scott R. Burell is a seasoned healthcare finance executive with over two decades of experience leading public life sciences companies through complex transactions and growth phases. Since August 2018, Mr. Burell has served as Chief Financial Officer and Secretary of AIVITA Biomedical, Inc., an immuno-oncology company, Mr. Burell previously served as CFO of CombiMatrix Corporation through its successful acquisition by Invitae Corp.

The Registrant issued a press release on August 7, 2025, announcing the appointment, a copy of which is filed as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Press Release dated August 8, 2025
104		Cover page interactive data file

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	DIH HOLDING US, INC.
Date: August 8, 2025	By:	/s/ Jason Chen
		Jason Chen Chief Executive Officer and Chairman

FAQ

What did DIH Holding US, Inc. (DHAI) announce in its latest 8-K?

The company appointed Scott R. Burell to its Board effective 4 Aug 2025.

Which board committees will Scott Burell join at DHAI?

He will serve on the Audit, Compensation, and Nominating & Corporate Governance Committees.

How long is Scott Burell’s term as a director of DHAI?

He is a Class III director with a term expiring at the 2026 annual shareholders’ meeting.

Does the 8-K disclose any related-party transactions or compensation for the new director?

No, the filing states there are no Item 404 transactions and provides no new compensation details.

Is there a press release related to this board appointment?

Yes. Exhibit 99.1 is a press release dated 7 Aug 2025 announcing Burell’s appointment.